Delivery Order SPE2DB22D2007-SPE2DB25FJ2GL

Award Date 6/12/25
Potential Completion Date 7/7/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medication, with a ceiling value of $10,916.78. The contract is a firm fixed-price delivery order with a period of performance ending on May 22, 2025. This order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product. The contract has a ceiling value of $5,320.92 and a completion date of October 16, 2024. It is a firm fixed-price contract, without any set-aside designation. AmerisourceBergen is the prime contractor and will be responsible for delivering the requested pharmaceutical product to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, with a ceiling value of $10,916.78. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product, with a ceiling value of $5,458.39. The contract is a firm-fixed-price delivery order, with an ultimate completion date of June 6, 2025. This contract is not set aside and is open to full and open competition....
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical product. The $10,641.84 firm fixed price contract has an ultimate completion date of November 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical products to support federal healthcare programs and military treatment facilities. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical products. The award, valued at $15,962.76, has an ultimate completion date of August 12, 2024. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery...
This is a $32,750.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, which is a pharmaceutical product. This contract is not set aside and is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,458.39, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceuticals. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,376,730 units of the pharmaceutical product PHESGO (1,200-600MG-30,000 unit, 15ML) at a ceiling value of $8,159.16. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,916.78 firm fixed-price contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML medical supplies, with a period of performance through March 18, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ2GL
    Delivery Order

This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product, with a ceiling value of $10,916.78. The contract is a firm fixed-price delivery order with a completion date of July 7, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. The DLA is the funding agency, and the contract is part of the company's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the agency, which provides comprehensive global pharmaceutical support to military healthcare programs.

Generated 9/11/25, 11:04 AM